US health official Fauci: Initial study of Moderna vaccine encouraging

Eren Sengezer FXStreet

The initial study of Moderna's coronavirus vaccine is encouraging, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, told CNBC on Friday.

"We can build on Remdesivir's success," Dr Fauci added. Earlier in the day, Dr Fauci told CNN that he was cautiously optimistic about Moderna's vaccine.

Market reaction

Wall Street's main indexes recovered modestly from session lows after these comments. As of writing, the Nasdaq Composite was flat on the day while the S&P 500 and the Dow Jones Industrial Average were down 0.25% and 0.5%, respectively.

Author

Eren Sengezer

FXStreet

As an economist at heart, Eren Sengezer specializes in the assessment of the short-term and long-term impacts of macroeconomic data, central bank policies and political developments on financial assets.

EUR/USD looks to regain the 200-day SMA

EUR/USD regains some balance and trade just above 1.1600 the figure ahead of the opening bell in Asia. The pair initially dipped to the 1.1530 zone for the first time since November, always following the stronger US Dollar and the marked flight-to-safety in the context of the ongoing Middle East crisis

GBP/USD attacks 1.3300, refreshing three-month lows

GBP/USD is deep in the red near 1.3300, accelerating its downside to renew three-month lows in European trading on Tuesday. The ongoing escalation in the Iran war, combined with rising Oil prices, weighs negatively on the higher-yielding Pound Sterling as the US Dollar capitalizes on increased haven demand.

Gold bounces off lows, back above $5,100

Gold remains on the defensive, eroding part of the recent multi-day advance and managing to trade back above the $5,100 mark per troy ounce on Tuesday. The precious metal initially dropped just below the critical $5,000 threshold on the back of the persistent strength of the Greenback, higher US Treasury yields across the curve and investors' repricing of Fed rate cuts.